University of Alabama, Birmingham

Feasibility of T cell immunotherapy for glioblastoma multiforme

Principal Investigator: Lawrence A. Lamb, PhD

Institute: University of Alabama, Birmingham

Initiative: Unrestricted Grant

Location: Birmingham, AL

Immunotherapy of Malignant Gliomas Using Cytokine-Producing delta gamma-1 34.5 HSV

Principal Investigator: Jacqueline N. Parker, PhD

Institute: University of Alabama, Birmingham

Initiative: Unrestricted Grant

Location: Birmingham, AL

Integrated pharmacogenomic/pharmacokinomic approach to optimize GBM therapy

Principal Investigator: Markus Bredel, MD, PhD

Institute: University of Alabama, Birmingham

Initiative: Mary Catherine Calisto Systems Biology Initiative

Location: Birmingham, AL

The role of FAK and Src in Glioma Invasion and Proliferation

Principal Investigator: Qiang Ding, PhD

Institute: University of Alabama, Birmingham

Initiative: North American Brain Tumor Consortium/New Approaches to Brain Tumor Therapy Grant

Location: Birmingham, AL

The Role of HCMV in Glioma Pathogenesis

Principal Investigator: Charles Cobbs

Institute: University of Alabama, Birmingham

Initiative: Charles B. Wilson Brain Tumor Research Excellence Grant

Location: Birmingham, AL

Principal Investigator: Charles Cobbs

Institute: University of Alabama, Birmingham

Initiative: Charles B. Wilson Brain Tumor Research Excellence Grant

Location: Birmingham, AL

Share